NCT06429514View on ClinicalTrials.gov

Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression

NACompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

May 3, 2024

Study Completion Date

May 3, 2024

Conditions
DepressionThyroid Cancer
Interventions
DIETARY_SUPPLEMENT

Ganoderma lucidum spore powder

One bag at a time, 2 times a day, 2g / bag

OTHER

placebo

One bag at a time, 2 times a day, 2g / bag

Trial Locations (1)

310022

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
collaborator

Zhejiang Shouxiangu Pharmaceutical Co,. Ltd.

INDUSTRY

lead

Ling Zhiqiang

OTHER